---
figid: PMC8361327__fcell-09-714298-g002
figtitle: Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1
  in Cancer
organisms:
- Adenoviridae
- Human papillomavirus
- Human papillomavirus type 16
- Human gammaherpesvirus 8
- Human T-cell leukemia virus type I
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
organisms_ner:
- Mus musculus
- Drosophila melanogaster
- Homo sapiens
- Rattus norvegicus
- Caenorhabditis elegans
pmcid: PMC8361327
filename: fcell-09-714298-g002.jpg
figlink: /pmc/articles/PMC8361327/figure/F2/
number: F2
caption: In malignant melanoma, extracellular stimulus signals are transmitted into
  cells through receptors on the membrane and can activate TWIST1 through RAS-RAF-MEK1/2-ERK1/2,
  PI3K-AKT-NFKB, and STAT3 pathways, respectively. TWIST1 can inhibit E-cadherin and
  promote the process of EMT. CADM1, generally highly expressed, can inhibit the activation
  of TWIST1 by inhibiting the RAS-ERK pathway and then inhibit the EMT process. CADM1
  can increase PARP-1 (poly ADP ribose polymerase) and recruit AIF (mitochondrial
  apoptosis inducing factor) and MIF (microphage migration inhibitory factor) to the
  nucleus, breaking down DNA into large fragments, and promoting cell death or inducing
  the destruction of mitochondrial membrane potential, leading to cell-dependent cell
  death. That is to say, elevated CADM1 can inhibit invasion and migration by inhibiting
  the EMT process or inducing cell death under non-adhesive conditions.
papertitle: Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1
  in Cancer.
reftext: Hongxu Li, et al. Front Cell Dev Biol. 2021;9:714298.
year: '2021'
doi: 10.3389/fcell.2021.714298
journal_title: Frontiers in Cell and Developmental Biology
journal_nlm_ta: Front Cell Dev Biol
publisher_name: Frontiers Media S.A.
keywords: CADM1 | proliferation | metastasis | biomarker | cancer
automl_pathway: 0.9418122
figid_alias: PMC8361327__F2
figtype: Figure
redirect_from: /figures/PMC8361327__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8361327__fcell-09-714298-g002.html
  '@type': Dataset
  description: In malignant melanoma, extracellular stimulus signals are transmitted
    into cells through receptors on the membrane and can activate TWIST1 through RAS-RAF-MEK1/2-ERK1/2,
    PI3K-AKT-NFKB, and STAT3 pathways, respectively. TWIST1 can inhibit E-cadherin
    and promote the process of EMT. CADM1, generally highly expressed, can inhibit
    the activation of TWIST1 by inhibiting the RAS-ERK pathway and then inhibit the
    EMT process. CADM1 can increase PARP-1 (poly ADP ribose polymerase) and recruit
    AIF (mitochondrial apoptosis inducing factor) and MIF (microphage migration inhibitory
    factor) to the nucleus, breaking down DNA into large fragments, and promoting
    cell death or inducing the destruction of mitochondrial membrane potential, leading
    to cell-dependent cell death. That is to say, elevated CADM1 can inhibit invasion
    and migration by inhibiting the EMT process or inducing cell death under non-adhesive
    conditions.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cadm1
  - Twist1
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Map2k1
  - Map2k2
  - Mapk3
  - Aifm1
  - Mif
  - Pik3r1
  - Akt1
  - Nfkb1
  - Parp1
  - Cdh1
  - Fzr1
  - Itk
  - Slc22a3
  - Ras64B
  - Ras85D
  - Raf
  - Dsor1
  - rl
  - AIF
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Dif
  - dl
  - Rel
  - Parp
  - im
  - shg
  - CADM1
  - TWIST1
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K1
  - MAP2K2
  - MAPK3
  - AIFM1
  - MIF
  - AMH
  - S100A8
  - S100A9
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - PARP1
  - CDH1
  - FZR1
  - ITK
  - SLC22A3
  - Pik3cg
  - mek-1
  - mek-2
  - parp-1
  - cdh-1
---
